Obesity, a complex chronic disease in itself, underlies many of the fatal cardiac and cardiometabolic diseases of the 21st century. Find a wide collection of expert guidance in this collection.
The Obesity Paradox: When is it Real?
Pharmacotherapy for Obesity Should Begin in Primary Care
Bariatric Surgery: Clinician and Patient Barriers to the First Conversation
Obesity Could Stymie Preventive Cardiology Efforts
________________________________________
Diet and Exercise Will Not Sustain Weight Loss in Obesity
Why Roux-en-Y Gastric Bypass Remains the Gold Standard in Bariatric Surgery
Adipose Tissue as an Endocrine Organ and its Role in Obesity
Waning Immunity in the Obese a Risk Factor for COVID-19
________________________________________
Obesity and COVID-19: Very Dangerous Together
Adipose Tissue in Obesity Linked to Prothrombotic State
Experts Anticipate Second-generation Weight-loss Drugs
Opening the Obesity Conversation in Primary Care
Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians
AHA Guidelines on Obesity for CVD Prevention: 5 Questions
What do you Know about Weight Loss Medications?
4 Questions for PCPs on Prevention and Management of Cardiometabolic Diseases
New Pledge to Abolish Pernicious Obesity Stigma
International Consensus Condemns Weight Bias
Obesity, Patients, & Physicians: Where do Attitudes Differ?
Why Not Talk About Bariatric Surgery: Why Patients & HCPs Hesitate
Why is Obesity Medicine the Fastest Growing Medical Specialty in the US?
Bariatric Surgery Shown to Increase Life Expectancy by 3 Years Compared to Usual Care
CDC: Adult Obesity Rising, Racial and Ethnic Disparities Still Exist
Weight Loss in Primary Care Augmented by Liraglutide plus Behavior Therapy
Weight Stigma Predicts Emotional Distress, Binge Eating in Young Adults during COVID-19
Metabolic Effects Comparable with Roux-en-Y vs Diet in Type 2 Diabetes
Obesity in the US: State by State
Bariatric Surgery Yields Therapeutic Hormonal Response